EUVIMEDSkopri EUVIMED
Open access · CC BY-NC 4.0

Clinical Evaluation of a BALIMONT Bifidobacterium–Lactobacillus plantarum Synbiotic Complex for Gut Microbiota and Bowel Function in Adults

Anas Ziraoui, Lorenzo Caruso, Zion Walker

Frontiers in Science and Engineering · 2026-04-22 · 6 (4) · 181-187

DOI: 10.54691/yr1bd653 ↗

At a glance

Journal article in Frontiers in Science and Engineering, published online on 2026-04-22. Written by Anas Ziraoui and 2 co-authors. 14 references. The full text is freely available (open access, CC BY-NC 4.0).

AstrattDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Background

We positioned a BALIMONT synbiotic composition built around freeze-dried Bifidobacterium longum, Bifidobacterium adolescentis, Lactobacillus plantarum, fructooligosaccharides, and stachyose for adult intestinal-health use. To place this formulation within a credible clinical framework, we integrated our retained formulation and preclinical observations with publicly available randomized trials and meta-analyses.

Methods

We searched the adult PubMed literature through March 2026 for randomized controlled trials, synbiotic/probiotic studies, and meta-analyses related to constipation, bowel function, gut microbiota, irritable bowel syndrome, Bifidobacterium, Lactobacillus plantarum, and prebiotic oligosaccharides.

Results

Public clinical evidence indicates that probiotics can shorten whole-gut transit time and improve stool frequency and stool consistency in functional constipation, with stronger pooled signals for multi-species formulations. A randomized trial containing Bifidobacterium longum showed earlier normalization of stool frequency and consistency, while synbiotic trials demonstrated gains in evacuation frequency and bowel regularity. In older adults with functional constipation, BL-99 plus fructooligosaccharides improved weekly spontaneous bowel movements and whole-gut transit time relative to placebo. For IBS-like symptoms, L. plantarum 299v and contemporary multistrain synbiotics demonstrated benefit in some adult populations, although the overall meta-analytic certainty remains low and strain heterogeneity is substantial.

Conclusions

The present formulation is best supported as a synbiotic intervention for bowel regularity, microbiota modulation, and symptom support. The most persuasive translational bridge comes from adult constipation and mixed functional gastrointestinal evidence, combined with our formulation architecture and preclinical observations.

Cite

APA

Ziraoui, A., Caruso, L., & Walker, Z. (2026). Clinical Evaluation of a BALIMONT Bifidobacterium–Lactobacillus plantarum Synbiotic Complex for Gut Microbiota and Bowel Function in Adults. Frontiers in Science and Engineering, 6(4), 181-187. https://doi.org/10.54691/yr1bd653

Vancouver

Ziraoui A, Caruso L, Walker Z. Clinical Evaluation of a BALIMONT Bifidobacterium–Lactobacillus plantarum Synbiotic Complex for Gut Microbiota and Bowel Function in Adults. Frontiers in Science and Engineering. 2026;6(4):181-187. doi:10.54691/yr1bd653

BibTeX
@article{Ziraoui2026,
  author = {Ziraoui, Anas and Caruso, Lorenzo and Walker, Zion},
  title = {Clinical Evaluation of a BALIMONT Bifidobacterium–Lactobacillus plantarum Synbiotic Complex for Gut Microbiota and Bowel Function in Adults},
  journal = {Frontiers in Science and Engineering},
  year = {2026},
  volume = {6},
  number = {4},
  pages = {181--187},
  doi = {10.54691/yr1bd653}
}
Start for free →